Foam sclerotherapy: Positioning within non-thermal ablation treatment

Summary

In recent years, ultrasound-guided foam sclerotherapy has become a firmly established treatment for varicose veins and offers many advantages compared with other ablation procedures. It is used without any type of anaesthesia, as the procedure is painless for the patient. By contrast, tumescent anaesthesia is required in thermal procedures, in order to protect surrounding structures and prevent unwanted nerve damage. This is not necessary with foam sclerotherapy.

Foam sclerotherapy is a rapid and simple treatment method for both large and small varicose veins and can be performed in the practice examination room. After duplex examination and detailed discussion of the treatment, the patient can be treated during the same session. Furthermore, in addition to the standard indications, foam sclerotherapy can also be used to treat recurrent varicose veins and tortuous vascular segments. In recent years, other non-thermal techniques have been developed in addition to foam sclero-therapy.

This article provides an overview of the position of foam sclerotherapy and the various non-thermal ablation techniques with regard to their efficacy, safety and side effects.

Keywords

Foam sclerotherapy - varicosis - ablation procedures

• References

• 1 Devereux N, Recke AL, Westermann L, Recke A, Kahle B. Catheter-directed foam sclerotherapy of great saphenous veins in combination with pre-treatment reduction of the diameter employing the principals of perivenous tumescent local anesthesia. Eur J Vasc Endovasc Surg 2014; 47 (02) 187-195.
• 2 Guex JJ. Endovenous chemical (and physical) treatments for varices: what’s new?. Phlebology 2014; 29 (Suppl. 01) 45-48. [Epub ahead of print]
• 3 Bishawi M, Bernstein R, Boter M. et al. Mechanochemical ablation in patients with chronic venous disease: A prospective multicenter study. Phlebology 2014; 29 (06) 397-400.
• 4 Elias S. et al. Mechanochemical tumescentless endovenous ablation: final results of the initial clinical trial. Phlebology 2012; 27: 67-72.
• 5 Lawson J, Gauw S, van Vlijmen C, Pronk P, Gaastra M, Mooij M, Wittens CH. Sapheon: the solution?. Phlebology 2013; Mar 28 (Suppl. 01) 2-9.